Thermo Fisher Scientific AcroMetrix User Manual

AcroMetrix™ CT/NG Control
For In Vitro Diagnostic Use
Rx Only
967146 AcroMetrix CT/NG Control
Intended Use
The AcroMetrix™ CT/NG Control is intended for use in assessing the performance of nucleic acid test procedures for the determination of the presence of CT and NG nucleic acid. Routine use of an external run control enables laboratories to monitor day-to-day test variation, lot-to-lot performance of test kits, and operator variation, and can assist in identifying increases in random or systematic error. This product is for in vitro diagnostic use.
Summary and Explanation
The AcroMetrix CT/NG Control contains inactivated Chlamydia trachomatis (CT) and inactivated Neisseria gonorrhoeae (NG) bacterial cells. The positive control was produced by diluting quantied CT and NG stock into a proprietary matrix. The AcroMetrix CT/NG Control is manufactured to provide a metrological traceable value and uncertainty according to ISO Standard 17511 (In vitro diagnostic medical devices- Measurement quantities in biological samples- Metrological traceability of values assigned to calibrators and control materials).
The AcroMetrix CT/NG Control is designed as an unassayed control for use in qualitative molecular test procedures for the detection of CT and NG nucleic acid.
Principles of the Procedure
The AcroMetrix CT/NG Control has been formulated to mimic naturally occurring human specimens containing CT and/or NG. Additionally, the intact bacterial format of the AcroMetrix CT/NG Control allows for the verication of effective bacterial nucleic acid extraction and purication. The controls are designed to monitor procedural steps in test procedures for determining the presence of CT and NG nucleic acid. The AcroMetrix CT/NG Control contains intact bacteria, and the test methodology must include an extraction step that releases the bacterial nucleic acid for amplication and detection, as appropriate to the test.
The AcroMetrix CT/NG Control is designed to help ensure the quality of nucleic acid test results and to monitor assay performance. Frequent testing of independent quality control samples provides the analyst with a means of monitoring the performance of laboratory assays. Routine use of these controls enables laboratories to monitor day-to-day test variation, lot-to-lot performance of test kits, and operator variation, and can assist in identifying increases in random or systematic errors.
Expected results utilizing the AcroMetrix CT/NG Control must be established by the end user for their particular assay.
Storage Instructions
It is recommended that the AcroMetrix CT/NG Control be stored at -20°C or below.
Do not use these products beyond the expiration date printed on the bottle label.
To avoid contamination use standard techniques and good laboratory practices when handling product.
Instructions for Use
Thaw the AcroMetrix CT/NG Control at room temperature, vortex briey, and aliquot contents entirely within 4 hours into amounts desired for use. Aliquot product into polypropylene screw cap vials (not supplied). Aliquots may be kept at 2-8°C for 25 days. Label aliquots with product description including Lot Number and Expiration date. It is recommended to aliquot into volumes appropriate for single use.
If aliquots are not to be used within 25 days, freeze aliquots at -20°C or below. When needed the frozen aliquots may be thawed then stored at 2-8°C, for up to 25 days. Do not refreeze aliquots.
Urine Specimen Protocol:
• Vortex control in liquid state thoroughly prior to use.
• Proceed with assay manufacturer’s instructions for processing of urine specimens, using input volume specied by assay manufacturers.
Swab Specimen Protocol:
• Vortex control in liquid state thoroughly prior to use.
• Pipette 100 uL of the control into assay manufacturer’s transport tube.
• Proceed with assay manufacturer’s instructions for processing of swab specimen.
Limitations
Reagents
Catalog Number Control Name Quantity
967146 AcroMetrix CT/NG Control 1 x 20 mL
Precautions and Warning
WARNING: Although the AcroMetrix CT/NG Control contains inactivated CT and NG, it should
be considered potentially biohazardous. Contains ≤25% Glycerol and ≤0.05% ProClin™ 300. Observe universal precautions for prevention of transmission of infectious agents when handling these materials.
H412 - Harmful to aquatic life with long lasting effects.
Avoid release to the environment. Dispose of contents/container to location in accordance with local/regional/national/international regulations.
Do not pipette by mouth. Use personal protective equipment, including lab coats, gloves and safety glasses. Do not eat, drink or smoke in areas where specimens are handled.
Disinfect liquids, materials or spills with a 0.5% sodium hypochlorite solution. Dispose of all materials and liquids used in the procedure as if they contained pathogenic agents.
This product contains 0.05% ProClin 300 as a preservative.
1, 2, 3
References
1. Centers for Disease Control (CDC). Recommendations for prevention of HIV transmission in health care settings. MMWR 1987; 36 (supplement no. 2S).
2. Centers for Disease Control (CDC). Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR 1988; 37:377-388.
3. Centers for Disease Control (CDC). Guidelines for prevention of transmission of human immunodeciency virus and hepatitis B virus to health-care and public-safety workers. MMWR 1989; 38(S-6): 1-36.
Glossary:
http://www.thermosher.com/symbols-glossary
Microgenics Corporation 46500 Kato Road Fremont, CA 94538 USA
0197
B·R·A·H·M·S GmbH Neuendorfstrasse 25
16761 Hennigsdorf, Germany US Customer and Technical Support: 1-800-232-3342
For insert updates go to: www.thermosher.com/Acrometrix
Microgenics Corporation is a wholly owned subsidiary of Thermo Fisher Scientific Inc.
© 2019 Thermo Fisher Scientic Inc. All rights reserved. ProClin is a trademark of Rohm and Haas Company. BD ProbeTec is a trademark of Becton, Dickinson and Company. Hologic, Gen-Probe and Aptima Combo 2 are trademarks of Gen-Probe Incorporated. Roche is a trademark of Roche Molecular Systems, Inc. cobas is trademark of Roche Diagnostics Operations, Inc. All other trademarks are the property of Thermo Fisher Scientic or its afliates.
MAN0007487-G-EN 2021 01
2
Loading...